Medtronic Resolute(TM) Drug-Eluting Stent (DES) Platform Receives Expanded Indication for Treatment of Chronic Total Occlusion (CTO) - BioSpace https://t.co/ksV5Z0smm4
— IDRO (@IDROOhio) February 27, 2019
from Twitter https://twitter.com/IDROOhio
February 27, 2019 at 10:32AM
No comments:
Post a Comment